Immunity against malarial sporozoites is mediated partially by neutralizing antibodies, but largely depends on antigen specific CD8+ T cells, thus vaccines are designed based on induction of infection-blocking CD8+ T cells [23], [24]. The gene discussed is CD8A; the disease is infection.